| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ATRICURE INC | 518,946 | 10,156,000 | 8.92% | ||
| 2 | NXSTAGE MED INC COM | 236,119 | 6,189,000 | 5.44% | ||
| 3 | ALDER BIOPHARMACEUTICALS INC | 221,013 | 4,597,000 | 4.04% | ||
| 4 | LOXO ONCOLOGY INC COM | 139,722 | 4,487,000 | 3.94% | ||
| 5 | GALAPAGOS NV | 66,068 | 4,241,000 | 3.73% | ||
| 6 | Sunesis Pharmaceuticals, Inc. | 1,133,583 | 4,104,000 | 3.61% | ||
| 7 | XENON PHARMACEUTICALS INC | 514,091 | 3,959,000 | 3.48% | ||
| 8 | AERIE PHARMACEUTICALS INC | 98,370 | 3,723,000 | 3.27% | ||
| 9 | BEIGENE LTD | 119,841 | 3,638,000 | 3.20% | ||
| 10 | DERMIRA INC | 98,800 | 2,997,000 | 2.63% | ||
| 11 | Foamix Pharmaceuticals Ltd. | 268,067 | 2,976,000 | 2.61% | ||
| 12 | INSULET CORPORATION | 73,484 | 2,769,000 | 2.43% | ||
| 13 | APPLIED GENETIC TECHNOL CORP | 286,298 | 2,677,000 | 2.35% | ||
| 14 | NEUROCRINE BIOSCIE COM USD0.001 | 66,008 | 2,555,000 | 2.24% | ||
| 15 | CYTOKINETICS INC | 210,306 | 2,555,000 | 2.24% | ||
| 16 | ARDELYX INC COM | 173,995 | 2,471,000 | 2.17% | ||
| 17 | INSULET CORP 2 06/15/2019 | 2,250,000 | 2,457,000 | 2.16% | PRN | |
| 18 | ISHARES TR | 8,700 | 2,309,000 | 2.03% | ||
| 19 | TESARO INC | 15,500 | 2,084,000 | 1.83% | ||
| 20 | IMMUNOMEDICS INC | 559,674 | 2,054,000 | 1.80% | ||
| 21 | RADIUS HEALTH | 53,854 | 2,048,000 | 1.80% | ||
| 22 | BLUEPRINT MEDICINES CORP COM | 72,500 | 2,034,000 | 1.79% | ||
| 23 | CARA THERAPEUTICS INC | 209,522 | 1,946,000 | 1.71% | ||
| 24 | DERMA SCIENCES INC COM PAR .01 | 353,718 | 1,839,000 | 1.62% | ||
| 25 | MACROGENICS INC | 89,200 | 1,823,000 | 1.60% | ||
| 26 | BIOTELEMETRY INC COM | 75,000 | 1,676,000 | 1.47% | ||
| 27 | CIDARA THERAPEUTICS INC | 159,918 | 1,663,000 | 1.46% | ||
| 28 | SPECTRANETICS CORP | 65,496 | 1,605,000 | 1.41% | ||
| 29 | TANDEM DIABETES CARE INC | 724,286 | 1,557,000 | 1.37% | ||
| 30 | PROTALIX BIOTHERAPEUTICS INC | 2,500,000 | 1,546,000 | 1.36% | PRN | |
| 31 | AEGLEA BIOTHERAPEUTICS INC COM | 350,392 | 1,524,000 | 1.34% | ||
| 32 | INOTEK PHARMACEUTICALS CORP | 237,135 | 1,447,000 | 1.27% | ||
| 33 | ADVAXIS INC COM NEW | 175,000 | 1,253,000 | 1.10% | ||
| 34 | UNIQURE NV | 203,907 | 1,142,000 | 1.00% | ||
| 35 | JOHNSON & JOHNSON | 9,400 | 1,083,000 | 0.95% | ||
| 36 | Ascendis Pharma | 53,000 | 1,073,000 | 0.94% | ||
| 37 | Protagonist Therapeutics, Inc. | 45,586 | 1,002,000 | 0.88% | ||
| 38 | ZOGENIX INC | 74,538 | 906,000 | 0.80% | ||
| 39 | Stereotaxis Inc | 1,372,862 | 892,000 | 0.78% | ||
| 40 | Exactech Inc | 31,636 | 864,000 | 0.76% | ||
| 41 | ArQule Inc | 668,735 | 843,000 | 0.74% | ||
| 42 | NEURODERM LTD | 37,921 | 842,000 | 0.74% | ||
| 43 | ACHILLION PHARMACEUTICALS INC COM | 196,500 | 812,000 | 0.71% | ||
| 44 | NOVADAQ TECHNOLOGIES INC | 101,841 | 722,000 | 0.63% | ||
| 45 | SYNERON MEDICAL LTD ORD SHS | 85,947 | 722,000 | 0.63% | ||
| 46 | Cogentix Medical Inc | 353,482 | 710,000 | 0.62% | ||
| 47 | IRONWOOD PHARMACEUTICALS INC | 600,000 | 690,000 | 0.61% | PRN | |
| 48 | CONCERT PHARMACEUTICALS INC COM | 66,968 | 689,000 | 0.61% | ||
| 49 | MASIMO CORP COM | 10,000 | 674,000 | 0.59% | ||
| 50 | INOTEK PHARMACEUTICALS CORP | 600,000 | 618,000 | 0.54% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-17-000014, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
